For example, the neurokinin 1 receptor antagonist aprepitant was shown to produce rapid and substantial inhibition of pruritus in 3 patients with CTCL (Sézary syndrome and MF) (83). Here, TACR1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.